Bettering the lives of individuals with DNM1L genetic variations
Welcome to the DNM1L Foundation, where we are dedicated to improving the lives of individuals and families affected by DNM1L genetic variations. Through research, education, and support, we aim to make a positive and impactful difference.
statistics
1 in 100,000 individuals worldwide
Living with DNM1L variations.
We aim to make a impactful difference.
Improving Lives Through Research and Education
The DNM1L Foundation is dedicated to connecting families, researchers, and medical professionals to improve the lives of those affected by DNM1L genetic disorders.
- Researching DNM1L genetic disorders to find effective treatments
- Connecting families, researchers, and medical professionals for support
- Providing benevolent assistance to patients and their families
our founding story
Oliver's Journey: From Missed Milestones to Rare Variation
Genetic Awareness
Understanding DNM1L Genetic Disorders and Their Impact
DNM1L genetic disorders are rare variations that can cause severe motor delays, optic atrophy, and even early infant mortality. We're working to improve lives.
Visualizing Our Impact
Oliver's Journey
Improving Lives Through Research, Education, and Assistance
Advancing Research Through Viability Studies
We invite researchers to join us in advancing our Viability Studies, where we're developing cell models and testing innovative approaches to find effective treatments for DNM1L variations. Your expertise can help us uncover critical solutions and bring hope to families affected.
Bringing Researchers, and Healthcare Providers Together
The partnership with Perlara, Inc. marks an important first step in our journey. But we know that one partnership alone isn't enough—we need many more to truly make a difference. Are you the next partner who can help us move forward together?
Assistance to Patients and Families
This is a community where we stand together, supporting families and patients as we push the boundaries of research. While we continue to search for answers, we no longer struggle alone—we rise together, as one united family.
Discovering New Treatments through Drug Repurposing
Our Partnership with Perlara, Inc.
We have partnered with Perlara, Inc. to conduct a drug repurposing study aimed at finding effective treatments for DNM1L variations. Through this study, we are working to identify readily available compounds that can better alleviate the symptoms associated.
Study Progress
In our inaugural study phase, we are developing fibroblast models and testing different cell assays.
Positive Results
We are seeking to test three different assay types: Cell painting, Bulk RNAseq, and CellTiter Glo.
Real Experiences
What Our Patients Are Saying
At our clinic, we value the feedback and experiences of our patients. Their stories reflect the care, dedication, and commitment we provide to ensure their well-being.
Thanks to the innovative treatments, my symptoms have lessened, and I finally feel like I can enjoy life again. Patients affected by DNM1L variations is truly inspiring.
Emily Johnson
Parent, ABC Company
The team truly listens and understands our struggles. I’ve seen remarkable progress, and I feel empowered on this journey affected by DNM1L variations is truly inspiring.
Emily Johnson
Parent, ABC Company
I am so grateful for the support I received. The treatments have significantly improved my daily life, and I feel hopeful for the future.
Emily Johnson
Parent, ABC Company
DNM1L Foundation has been a beacon of hope for our family. Their dedication to improving the lives of patients affected by DNM1L variations is truly inspiring.
Emily Johnson
Parent, ABC Company
Join our supportive community today
Make a difference by donating and participating in our community